Turn Therapeutics Inc.
NASDAQ:TTRXBiotechnology
-$0.17 today
- Market cap
- $264.15M
- Beta
- 2.77
- P/E (TTM)
- -45.0
- EPS (TTM)
- -$0.13
Volume 0.13M
Average 0.04M
Returns on capital
Turn Therapeutics Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-68.2%
avg -581.4%
ROIC
-94.4%
avg -124.5%
ROA
-26.3%
avg -75.5%
Analysis
ROA is currently the strongest return metric at -26.3% versus its period average of -75.5%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Bradley E. Burnam | Founder, Chief Executive Officer & Director | USD 465.74K | 47 | — | — |
Zuraiz Chaudhary | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer | USD 365.31K | 31 | — | — |
Robert R. Redfield | Chief Scientific Officer | — | 75 | — | — |
Neilesh Shailesh Ghodadra | Chief Medical Officer & Director | — | 46 | — | — |
Stephen Hahn FASTRO | Executive Clinical & Regulatory Lead | — | 66 | — | — |
Mohammed Zubair | Controller | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
No open-market purchases or sales in the last 12 months.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Who does Turn Therapeutics Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about TTRX's management, answered from reported figures.
Who manages TTRX?
Turn Therapeutics Inc. (TTRX) lists 6 active executives. The top listed executive is Zuraiz Chaudhary, Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer.
Continue the stock analysis
Jump to another research area for this company.